发明名称 Compositions and methods of delivery of pharmacological agents
摘要 The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human serum albumin and/or deferoxamine. The human serum albumin is present in an amount effective to reduce one or more side effects associated with administration of the pharmaceutical composition. The invention also provides methods for reducing one or more side effects of administration of the pharmaceutical composition, methods for inhibiting microbial growth and oxidation in the pharmaceutical composition, and methods for enhancing transport and binding of a pharmaceutical agent to a cell.
申请公布号 US9012518(B2) 申请公布日期 2015.04.21
申请号 US201313777980 申请日期 2013.02.26
申请人 Abraxis BioScience, LLC 发明人 Desai Neil P.;Soon-Shiong Patrick;Trieu Vuong
分类号 A61K47/42;A61K9/14;A61K9/51;C07K14/76;A61P35/00;A61K9/00;A61K9/107;A61K9/19;A61K31/05;A61K31/16;A61K31/337;A61K47/18;B82Y5/00;A61K31/164;A61K31/165;A61K31/198;A61K31/343;A61K31/355;A61K31/427;A61K31/436;A61K31/4745;A61K31/7048;A61K38/13 主分类号 A61K47/42
代理机构 Morrison & Foerster LLP 代理人 Morrison & Foerster LLP
主权项 1. A method of treating cancer in a human individual, comprising injecting into the individual an effective amount of a pharmaceutical composition comprising paclitaxel and a pharmaceutically acceptable carrier, wherein the pharmaceutically acceptable carrier comprises albumin, wherein the albumin and the paclitaxel in the composition are formulated as particles, wherein the particles in the composition have a particle size of less than about 200 nm, and wherein the weight ratio of albumin to paclitaxel in the composition is about 1:1 to about 9:1, wherein the cancer is ovarian cancer.
地址 Los Angeles CA US